NFKBIZ and psoriasis: Consistently, dimethyl itaconate can selectively regulate secondary, but not primary, transcriptional responses to TLR stimulation via inhibition of IκBζ protein induction by ATF3 while dimethyl itaconate ameliorates IL-17–IκBζ-driven skin pathology in a mouse model of psoriasis (171).